Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Proven Techniques for Reining In Supply Chain Costs

Proven Techniques for Reining In Supply Chain Costs Healthcare delivery in the United States is experiencing a period of extreme flux and uncertainty that is combining to escalate costs. It is compounded by a healthcare supply chain which is vast, complex and plagued with inefficiencies. Supply costs can account for 25-30% of a hospital’s operating…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

Proven Techniques for Reining In Supply Chain Costs

Healthcare delivery in the United States is experiencing a period of extreme flux and uncertainty that is combining to escalate costs. It is compounded by a healthcare supply chain which is vast, complex and plagued with inefficiencies. Supply costs can account for 25-30% of a hospital’s operating budget. Supplies relate directly to the patient experience, making it difficult to always settle for the least expensive option. Consequently, hospitals are continually faced with the challenge of decreasing supply chain costs without compromising patient care.

Supply Chain and Physician Preference Items

The balance of cost and function may be most true with Physician Preference Items (PPI) that can account for up to 60% of supply spend. As individual physicians typically select those specific tools with which they are most comfortable, PPI products can be extremely varied across the hospital. This variance, coupled with the high cost of PPI products, makes it difficult for hospital administrators to reduce spend across their organization. In order to keep supply spend in check, healthcare administrators must work collaboratively with physicians and their established preferences to address the financial bottom line and efforts to reduce costs while also improving efficiencies. It’s a collective approach among all stakeholders to balance cost, quality and outcomes.

One opportunity to significantly reduce supply chain inefficiencies and costs is through product standardization. By eliminating the number of similar products, hospitals are able to negotiate more aggressively with vendors to achieve higher value. When it comes to PPI, consideration should be made to determine which items are “preference” driven versus clinically necessary.

Standardizing physician preference items requires involving physicians in the process and educating them with clinical and financial data of clinical utilization patterns, patient outcomes, and product costs and value. While a complex and involved process, the savings extracted from a strategic focus on PPI is well worth the time and investment. TPC is a proven leader in assessing PPI opportunities, collaborating with physicians, and developing successful PPI programs that reduce supply spend without compromising clinical quality or patient care.

TPC Focus on Supply Chain and Physician Preference Items

The TPC model enables hospitals to aggregate their volume to wield increased purchasing power. By drawing upon the combined expertise of Members, TPC gives physicians, nurses, pharmacists and other clinical specialists a method to evaluate products and assess their financial value, as well as their impact on the quality of care. We have found a niche in custom contracting for high-value, complex PPI categories, such as spine and cardiology. By initiating conversations with physicians early in the process we can more effectively evaluate and analyze differences across products and vendors.

TPC collaborates with Members to create a better understanding of the market landscape and drive better decision making. Together, we level-set technology across multiple manufacturers in complex categories and drive standardization in pricing. TPC works with Clinical Value Analysis Teams (CVATs) and Physician Sub-Committees (PSCs) comprised of clinical leaders from each Member facility. These groups offer functionally equivalent, cost-effective solutions to promote a culture of clinical excellence and financial stewardship for all TPC Members. Functional equivalence is determined by objective review of the product using specific, predetermined criteria, and not based on clinical or operational preference. The members of CVATs and PSCs are of vital importance as they serve as clinical advisors, initiative champions and provide clinical input into product decisions.

Through TPC’s custom contracts, Members have achieved significant savings in multiple product categories including, $3.45 million in Cardiac Rhythm Management, $3.5 million in Spinal Implants, and $1.6 million in Interventional Cardiology. As healthcare systems across the country are seeking ways to generate cost savings in the complex category of supply chain, the TPC collaborative model has proven results in reducing supply chain expenses, especially in the challenging area of PPI.

Stronger Together. Superior Results. To learn more about TPC services for supply chain savings, visit http://www.tpc1.com/supply-chain/ today!

Read more at tpc1.com

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one expert. Imagine publishing your whole team.

This article was produced through MarketScale. Create a free workspace and turn your own team's expertise into articles, video, and social posts. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

IQVIA's new white paper maps how digital health technologies can reshape CNS clinical trial endpoints

IQVIA's new white paper maps how digital health technologies can reshape CNS clinical trial endpoints

IQVIA's white paper provides a framework for validating digital endpoints in CNS clinical trials, focusing on digital health technologies such as sensors, software, and connected devices. These technologies have the potential to reshape clinical trial endpoints in neurological studies. The white paper aims to guide the integration of digital health solutions in measuring clinical outcomes.

  • 01Digital health technologies like sensors and software can reshape CNS clinical trial endpoints.
  • 02Validating digital endpoints in clinical trials is crucial for integrating technology in CNS studies.
  • 03IQVIA offers a framework for using connected devices in clinical research.

Jul 16, 2026

Clinical AI safety, intelligent ventilators, and payment accuracy: health tech's big moves on July 15

Clinical AI safety, intelligent ventilators, and payment accuracy: health tech's big moves on July 15

On July 15, significant health technology announcements highlighted advancements in AI safety benchmarks, smarter critical-care equipment, and autonomous front-office tools. These developments indicate a strong push towards integrating intelligent systems in healthcare to enhance patient care and operational efficiency.

  • 01AI safety benchmarks are being established to ensure intelligent technologies are safely integrated into healthcare systems.
  • 02Intelligent ventilators and smarter critical-care tools are being developed to improve patient outcomes in healthcare settings.
  • 03Autonomous front-office tools are being introduced to streamline administrative tasks in healthcare facilities.

Jul 16, 2026

Saudi Arabia's digital health push: what a $77 billion market means for enterprise operators

Saudi Arabia's digital health push: what a $77 billion market means for enterprise operators

Saudi Arabia is set to expand its healthcare market with expenditures predicted to reach $77.1 billion by 2027, partly driven by advancements in digital health technologies. Digital health revenue is expected to exceed $1 billion by 2029, with an anticipated user base of 16.2 million. This growth represents significant opportunities for enterprise operators in the healthcare sector.

  • 01Saudi Arabia's healthcare spend is projected to reach $77.1 billion by 2027.
  • 02The digital health market in Saudi Arabia is expected to generate over $1 billion in revenue by 2029.
  • 03An estimated 16.2 million users will engage with digital health services in Saudi Arabia by 2029.

Jul 16, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512